I have decided about my COVID-19 vaccine, what about my child?

Shlomit Hon Snir1, Sharon Teitler Regev1

  • 1Department of Economic and Management, Yezreel Valley College, Yezreel Valley, Israel.

Insights

Parental willingness to vaccinate children against COVID-19 increases with age, influenced by perceived benefits and trust. A holistic approach is key to understanding these factors for pediatric vaccination acceptance.

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • COVID-19 vaccination campaigns have been crucial in controlling the pandemic.
  • Vaccine acceptance for pediatric populations remains a concern for some parents.
  • Israel's vaccination program initially targeted individuals 16 and older, later extending to 12 and older.

Purpose of the Study:

  • To investigate parental acceptance of pediatric COVID-19 vaccination.
  • To identify factors influencing vaccination willingness across different child age groups.
  • To apply a holistic approach combining various determinants of vaccine acceptance.

Main Methods:

  • Online questionnaire distributed in April 2021.
  • Survey data collected from 516 parents.
  • Analysis incorporating factors from existing vaccine acceptance literature.

Main Results:

  • Pediatric COVID-19 vaccine acceptance rates varied by age group: 44.7% (0-6), 53.2% (6-12), and 66.4% (12-16).
  • Perceived vaccine benefits positively correlated with parental willingness to vaccinate.
  • For ages 12-16, willingness was linked to information access, trust, and community norms; perceiving information as "fake news" also increased willingness.

Conclusions:

  • Parental willingness to vaccinate children against COVID-19 is age-dependent.
  • A comprehensive, holistic approach is necessary to understand the multifaceted variables influencing parental decisions.
  • Addressing parental concerns regarding benefits, information reliability, trust, and community influence is vital for promoting pediatric vaccination.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
45.2K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
488
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
185
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K